BIONANO GENOMICS INC (BNGO)
US09075F3055 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.76M | 17.95M | 5.10M | 24.60M | 38.40M | |||
| Marketable Securities | 12.56M | 48.82M | 108.10M | 226.00M | 0.00 | |||
| Receivables | 8.31M | 9.66M | 7.50M | 5.30M | 2.80M | |||
| Inventories | 19.59M | 22.89M | 29.80M | 12.40M | 3.30M | |||
| Other Current Assets | 29.39M | 40.79M | 6.80M | 4.00M | 2.30M | |||
| Total Current Assets | 85.61M | 140.12M | 157.30M | 272.40M | 46.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 33.60M | 32.48M | 29.00M | 20.90M | 4.90M | |||
| Goodwill | N/A | 0.00 | 77.30M | 56.20M | 7.20M | |||
| Intangibles | 31.73M | 33.97M | 41.10M | 26.80M | 1.50M | |||
| Other Non-Current Assets | 7.05M | 7.83M | 2.80M | 700.00K | 100.00K | |||
| Total Non-Current Assets | 72.38M | 74.29M | 150.20M | 104.70M | 13.70M | |||
| TOTAL ASSETS | 158.00M | 214.40M | 307.50M | 377.10M | 60.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 269.00K | 272.00K | 300.00K | 300.00K | 0.00 | |||
| Accrued Expenses | 12.17M | 9.14M | 12.00M | 10.50M | 5.00M | |||
| Accounts Payable | 9.84M | 10.38M | 12.50M | 9.70M | 2.90M | |||
| Other Current Liabilities | 36.23M | 80.24M | 11.10M | 1.40M | 1.00M | |||
| Total Current Liabilities | 58.51M | 100.03M | 35.90M | 21.80M | 8.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.58M | 3.58M | 3.60M | 3.60M | 16.30M | |||
| Other Non-Current Liabilities | 13.14M | 14.63M | 18.60M | 14.50M | 100.00K | |||
| Total Non-Current Liabilities | 16.72M | 18.22M | 22.20M | 18.20M | 16.50M | |||
| TOTAL LIABILITIES | 75.22M | 118.25M | 58.10M | 40.00M | 25.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -612.63M | -581.21M | -348.70M | -216.10M | -143.70M | |||
| Additional Paid In Capital | 695.41M | 677.34M | 599.20M | 553.70M | 178.70M | |||
| Common Shares | 6.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -16.00K | 23.00K | -1.10M | -500.00K | 0.00 | |||
| Shares Outstanding | 57.54M | 45.75M | 29.70M | 29.00M | 19.00M | |||
| Tangible Book Value per Share | 0.89 | 1.36 | 4.41 | 8.76 | 1.39 | |||
| Total Shareholders' Equity | 82.77M | 96.16M | 249.40M | 337.10M | 35.10M | |||
| TOTAL LIABILITIES AND EQUITY | 158.00M | 214.40M | 307.50M | 377.10M | 60.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.04 | 0.01 | 0.01 | 0.46 | |||
| Current Ratio | 1.46 | 1.40 | 4.38 | 12.50 | 5.26 | |||
| Return On Assets (ROA) | -143.54% | -108.44% | -43.12% | -19.21% | -67.95% | |||
| Return On Equity (ROE) | -274.00% | -241.78% | -53.17% | -21.49% | -117.12% | |||
All data in USD